Variable | Total sample n = 141 | Rheumatology n = 83 | Psychosomatic n = 58 |
---|---|---|---|
Age in years, mean ± SD (range) | 53.3 ± 16.2 (19–86) | 55.2 ± 17.4 (19–86) | 50.6 ± 14.1 (24–80) |
Sex, n (%) | Â | Â | Â |
Female | 95 (67.4) | 58 (69.9) | 37 (63.8) |
Male | 46 (32.6) | 25 (30.1) | 21 (36.2) |
Nationality | Â | Â | Â |
German | 125 (88.7) | 72 (86.7) | 53(91.7) |
Non-German | 7 (4.9) | 7 (8.4) | 0 (00.0) |
Unknown | 9 (6.4) | 4 (4.8) | 5 (8.6) |
Living status, n (%) | Â | Â | Â |
With partner | 88 (62.4) | 53 (63.9) | 35 (60.3) |
Single | 39 (27.7) | 24 (28.9) | 15 (25.9) |
Other | 8 (5.7) | 5 (6.0) | 3 (5.2) |
Unknown | 6 (4.2) | 1 (1.2) | 5 (8.6) |
Educational level (ISCED 19971), n (%) | Â | Â | Â |
Doctoral degree or equivalent | 3 (2.1) | 2 (2.4) | 1 (1.7) |
Bachelor’s/Master’s degree or equivalent | 45 (32.0) | 31 (37.3) | 14 (24.1) |
Degree of post-secondary/tertiary education | 43 (30.5) | 25 (30.1) | 18 (31.0) |
Degree of secondary education | 12 (8.5) | 8 (9.6) | 4 (6.9) |
Degree of primary education | 28 (19.9) | 15 (18.1) | 13 (22.4) |
Without | 4 (2.8) | 1 (1.2) | 3 (5.2) |
Unknown | 6 (4.2) | 1 (1.2) | 5 (8.6) |
Work status, n (%) | Â | Â | Â |
Full-time | 20 (14.2) | 11 (13.3) | 9 (15.5) |
Part-time | 8 (5.7) | 7 (8.4) | 1 (1.7) |
Seeking employment | 4 (2.8) | 1 (1.2) | 3 (5.2) |
Not employed (student, retired, freelancer) | 48 (34.0) | 20 (24.1) | 28 (48.3) |
Unable to work for health reasons | 51 (36.2) | 36 (43.4) | 15 (25.9) |
Unknown | 10 (7.1) | 5 (6.0) | 5 (8.6) |
Primary conditions, n (%) | Â | Â | Â |
Persistent somatoform pain disorder (PSPD)2 | Â | Â | 58 (100.0) |
Arthritis | Â | 19 (22.9) | Â |
Systemic sclerosis (SScl) | Â | 17 (20.5) | Â |
Systemic lupus erythematosus (SLE) | Â | 13 (15.7) | Â |
Vasculitis | Â | 11 (13.3) | Â |
Others3 | Â | 11 (13.3) | Â |
Sjogren’s syndrome (SS) |  | 9 (10.8) |  |
Ormond’s disease |  | 3 (3.6) |  |
Domain scores, M (SD) | Â | Â | Â |
EQ-5D-5L Mobility4 | 2.50 (1.14) | 2.34 (1.15) | 2.72 (1.09) |
EQ-5D-5L Self-care4 | 1.67 (0.92) | 1.63 (0.92) | 1.72 (0.93) |
EQ-5D-5L Usual Activities4 | 2.85 (1.26) | 2.64 (1.30) | 3.16 (1.15) |
EQ-5D-5L Pain/Discomfort4 | 3.02 (1.10) | 2.60 (1.01) | 3.62 (0.95) |
EQ-5D-5L Anxiety/Depression4 | 2.28 (1.15) | 1.87 (0.93) | 2.88 (1.19) |
PROPr Cognition5 | 48.18 (6.65) | 49.68 (7.13) | 46.04 (5.52) |
PROPr Depression6 | 55.39 (9.90) | 53.17 (9.19) | 58.57 (10.08) |
PROPr Fatigue6 | 57.26 (9.25) | 55.13 (9.70) | 60.31 (7.67) |
PROPr Pain6 | 62.03 (8.16) | 59.72 (8.90) | 65.33 (5.56) |
PROPr Physical Function5 | 41.54 (8.59) | 42.12 (8.58) | 40.69 (8.60) |
PROPr Sleep Disturbance6 | 52.32 (8.24) | 50.59 (8.42) | 54.79 (7.35) |
PROPr Ability to Participate in Social Roles5 | 44.48 (8.62) | 46.57 (9.00) | 41.24 (6.91) |
Health States Utilities, M (95%CI) [Range] | Â | Â | Â |
PROPr | 0.26 (0.23; 0.29) [− 0.004; 0.955] | 0.32 (0.27; 0.36) [0.009; 0.995] | 0.18 (0.15; 0.21) [− 0.004; 0.53] |
EQ-5D-5L index value (US 5L Value Set) | 0.44 (0.38; 0.51) [− 0.425; 1.00] | 0.57 (0.50;0.65) [− 0.425; 1.00] | 0.26 (0.17; 0.36) [− 0.329; 1.00] |